The exercise price for subscription of warrants of series TO3A and TO3B in Scandinavian ChemoTech AB has been set at SEK 4.79 per share, the exercise period begins April 11
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES THAN SUCH MEASURES WHICH FOLLOWS FROM SWEDISH REGULATIONS. Scandinavian ChemoTech AB (“Scandinavian ChemoTech” or the “Company”) completed a rights issue of units in October 2022. Each (1) unit of series A consisted of one (1) newly issued